- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00520117
Assessing the Psychosocial Burden in Women With an Abnormal Pap Results After Screening Interventions
September 27, 2019 updated by: Punnee Pitisuttithum, Mahidol University
The primary purpose of this study is to assess the psychosocial burden in women who have experienced an abnormal pap results after screening interventions.
Study Overview
Status
Completed
Conditions
Detailed Description
This study will be a Thailand, clinic-based, cross-sectional, questionnaire study.
Approximately 151 female participants will be enrolled.
Study staff will interview the subject to collect basis demographic data and self reported medical history.
And the subjects will be given the questionnaire packet for self-administration.
After subjects complete the packet, study staff will review the questionnaires for completeness prior to the study subject leaving the clinic.
Study Type
Observational
Enrollment (Actual)
151
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bangkok, Thailand, 10400
- Clinical Infectious Diseases Research Unit
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Patients having pap-smear at Ratchawithi Hospital
Description
Inclusion Criteria:
- female, between 18 and 45 years of age and must have recently experienced an abnormal pap results within the past 3 months.
Exclusion Criteria:
- has any condition which in the opinion of the investigator might interfere with the evaluation of the study objectives
- has other concurrent/active STD's
- has a history of known prior vaccination with an HPV vaccine
- has a history of recent (within 1 year from date of enrollment) or ongoing alcohol abuse or other drug abuse.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
|---|
|
negative pap-smear
|
|
positive pap-smear
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
psychological burden of women with abnormal pap-smear
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Punnee Pitisuttithum, Professor, Department of Clinical ITropical Medicine, Faculty of Tropical Medicine, Mahidol University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2007
Primary Completion (Actual)
June 1, 2008
Study Completion (Actual)
June 1, 2008
Study Registration Dates
First Submitted
August 22, 2007
First Submitted That Met QC Criteria
August 22, 2007
First Posted (Estimate)
August 23, 2007
Study Record Updates
Last Update Posted (Actual)
September 30, 2019
Last Update Submitted That Met QC Criteria
September 27, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- 2007-024
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Papanicolaou Smear
-
Eisenhower Army Medical CenterPearl NetworkWithdrawn
-
University of BergenCompleted
-
Taichung Veterans General HospitalCompletedUnsatisfactory Pap SmearTaiwan
-
Washington University School of MedicineCompletedColposcopy | Abnormal Pap SmearUnited States
-
Universiteit AntwerpenCompletedHPV-related Cytological Abnormalities on PAP Smear (LSIL)Belgium
-
Dow University of Health SciencesUniversity of KarachiCompleted
-
Qurient Co., Ltd.CompletedTreatment-naïve, Sputum Smear-positive Patients With Drug-sensitive Pulmonary TBSouth Africa
-
Turkish Ministry of Health, Kahramanmaras Provincial...CompletedCervical Cancer | Smear LayerTurkey
-
Postgraduate Institute of Dental Sciences RohtakCompletedApical Periodontitis
-
University Hospital, BrestTerminatedCervical Cancer | HPV Vaccination | Pap Smear | Catch-up VaccinationFrance